Document is current
Any future updates will be listed below
-
Authors
Jung, Ji Yoon https://orcid.org/0000-0002-2017-4994
Chon, Hong Jae https://orcid.org/0000-0002-6979-5812
Choi, Young Jin https://orcid.org/0000-0002-3525-8154
Yeon, Sang Eun https://orcid.org/0000-0002-9682-7955
Choi, Seok Young https://orcid.org/0000-0002-6542-2963
Lee, Kyung Hee https://orcid.org/0000-0003-0462-2512
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 15 March 2022
First Online: 14 April 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki, and the study protocol was approved by the respective Institutional Review Board of each center.
: Informed consent was obtained from all individual participants included in the study.
: The included patients signed an informed consent form for the use of personal information in connection with post-marketing surveillance.
: Ji Yoon Jung, Young Jin Choi, Kyung Hee Lee have no conflicts of interest to declare. Hong Jae Chon has received honoraria from Eisai, Roche, Bayer, ONO, MSD, BMS, Celgene, Sanofi, Servier, AstraZeneca, Sillajen, Menarini, GreenCross Cell, Boryung Pharmaceuticals, and Dong-A ST, and has received research grants from Roche, Dong-A ST, Boryung Pharmaceuticals. Sang Eun Yeon and SeokYoung Choi are employees of Janssen Korea Ltd.
